Yıl 2021, Cilt 13 , Sayı 2, Sayfalar 292 - 331 2021-06-30

Effectiveness of Third Wave Therapies for Treatment of Obsessive-Compulsive Disorder: A Review
Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme

Gizem ONARAL [1]


In the treatment of obsessive-compulsive disorder, the effectiveness of two main treatment approaches, pharmacotherapy and cognitive behavioral therapy (CBT), has been proven. However, the high rates of drop out from treatment and the presence of residual symptoms after CBT direct researchers to look for different treatment approaches. Therefore, emerging developments show that Third Wave Therapies are promising. In this review; it is aimed to summarize the theoretical background of Third Wave Therapies used in the treatment of obsessive-compulsive disorder and to review the effectiveness of these approaches and examine these studies in terms of methodological perspective and therapy content. In accordance with this purpose, studies which examine the effectiveness of Acceptance and Commitment Therapy, Mindfullness-Based Therapy, Metacognitive Therapy, Schema Therapy and Dialectical Behavior Therapy which are published in English/Turkish between 2004-2020 years and accessed from 5 databases: Ebscohost, Ulakbim, Google Scholar, Science Direct and Web of Science are included. As a result of this review, it has been determined that Third Wave Therapies generally reduce obsessive-compulsive symptoms and result in both reductions on depression, anxiety and stress symptoms and improvements on skills such as self-compassion and mindfulness. Based on these results, it was concluded that the first evidences about the effectiveness of Third Wave Therapies in the adult population in the treatment of obsessive-compulsive disorder begin to accumulate, but there is a need for randomize clinical controlled trials which is performed with larger samples and compared with cognitive behavioral therapy, exposure and response prevention or pharmacotherapy.
Tekrarlayan obsesyonlar ve/veya kompulsiyonlar ile karakterize olan Obsesif-Kompulsif Bozukluk tedavisinde ilaç tedavisi ve Bilişsel Davranışçı Terapi olmak üzere 2 ana tedavi yaklaşımının etkililiği kanıtlanmış görünmektedir. Ancak tedaviyi yarıda bırakma oranlarının yüksek olması ve BDT sonrası kalıntı belirtilerin görülmesi, araştırmacıları farklı tedavi yaklaşımlarına yöneltmiştir. Bu bağlamda ortaya çıkan yeni gelişmeler, 3. Kuşak Terapiler açısından umut vermektedir. Bu gözden geçirme çalışmasında; Obsesif-Kompulsif Bozukluk’un tedavisinde kullanılan 3. Kuşak Terapilerin kuramsal alt yapısının özetlenmesi, bu bağlamdaki terapi yaklaşımlarının etkililiğine dair araştırmaların yöntemsel ve terapi süreci açısından gözden geçirilmesi amaçlanmıştır. Bu amaçla bu gözden geçirme çalışmasında; 2004-2020 yılları arasında İngilizce/Türkçe dilinde yayınlanmış ve Ebscohost, Ulakbim, Google Akademik, Science Direct ve Web of Science olmak üzere 5 veri tabanından ulaşılan Kabul ve Kararlılık Terapisi, Bilinçli Farkındalık Temelli Terapi, Üstbilişsel Terapi, Şema Terapi ve Diyalektik Davranış Terapisi’nin obsesif-kompulsif bozukluk’taki etkililiğini inceleyen araştırmalara yer verilmiştir. Yapılan gözden geçirme sonucunda, 3. Kuşak Terapiler’in genel olarak obsesif kompulsif belirtileri azalttığı görülmüştür. Buna ek olarak, depresyon, anksiyete ve stres belirtilerinde azalma; öz-şefkat ve bilinçli farkındalık gibi becerilerde ise artış sağladığı belirlenmiştir. Buradan yola çıkarak, Obsesif-Kompulsif Bozukluk tedavisinde 3. Kuşak Terapiler’in yetişkin örneklemindeki etkililiğine dair ilk kanıtların birikmeye başladığı ancak daha büyük örneklemler ile bilişsel davranışçı terapi, maruz bırakma ve tepki önleme ya da ilaç tedavisi ile karşılaştırmalı olarak yapılan seçkisiz kontrollü klinik çalışmalara ihtiyaç olduğu sonucuna ulaşılmıştır.
  • Abramowitz JS (2006) The psychological treatment of obsessive–compulsive disorder. Can J Psychiatry, 51:407-416.
  • Andouz Z, Dolatshahi B, Moshtagh N ve Dadkhah A (2012) The efficacy of metacognitive therapy on patients suffering from pure obsession. Iran J Psychiatry, 7:11-21.
  • Brauer L, Lewin AB ve Storch EA (2011) A review of psychotherapy for obsessive-compulsive disorder. Mind & Brain, the Journal of Psychiatry, 2:38-44.
  • Cludius B, Landmann S, Rose N, Heidenreich T, Hottenrott B, Schröder J, Jelinek L et al. (2020) Long-term effects of mindfulness-based cognitive therapy in patients with obsessive-compulsive disorder and residual symptoms after cognitive behavioral therapy: twelve-month follow-up of a randomized controlled trial. Psychiatry Res, 291:113-119.
  • Çilli AS, Telcioğlu M, Aşkın R, Kaya N, Bodur S ve Kucur R (2004) Twelve-month prevalence of obsessive-compulsive disorder in Konya, Turkey. Compr Psychiatry, 45:367-374.
  • Dehlin JP, Morrison KK ve Twohig MP (2013) Acceptance and commitment therapy as a treatment for scrupulosity in obsessive compulsive disorder. Behav Modif., 37:409–430.
  • de Zoysa P (2011) The use of mindfulness practice in the treatment of a case of obsessive compulsive disorder in Sri Lanka. J. Relig. Health, 52:299–306.
  • Didonna F, Lanfredi M, Xodo E, Ferrari C, Rossi R ve Pedrini L (2019) Mindfulness-based cognitive therapy for obsessive-compulsive disorder: a pilot study. J Psychiatr Pract, 25:156–170.
  • Dougherty DD, Rauch SL ve Jenike MA (2004) Pharmacotherapy for obsessive-compulsive disorder. J Clin Psychol, 60:1195–1202.
  • Ersoy F, Edirne DT ve Oğuz TF (2003) Birinci basamakta anksiyete bozuklukları – 3. Sürekli Tıp Eğitimi Dergisi, 12:366-369.
  • Fineberg NA, Baldwin DS, Drummond LM, Wyatt S, Hanson J, Gopi S et al. (2018) Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. Int Clin Psychopharmacol, 33:334-348.
  • Fisher PL ve Wells A (2005) How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis. Behav Res Ther, 43:1543–1558.
  • Fitt S ve Rees C (2012) Metacognitive therapy for obsessive compulsive disorder by videoconference: a preliminary study. Behaviour Change, 29:213–229.
  • Gururaj GP, Bada Math S, Reddy JYC ve Chandrashekar CR (2008). Family burden, quality of life and disability in obsessive compulsive disorder: an Indian perspective. J Postgrad Med, 54:91-97.
  • Gündoğan A, Saltukoğlu G ve Astar M (2020) Bilinçli farkındalık temelli bilişsel terapi programının obsesif kompulsif belirtiler üzerindeki etkisi. Uluslararası Toplum Araştırmaları Dergisi, 15:968-993.
  • Hauschildt M, Schröder J ve Moritz S (2016) Randomized-controlled trial on a novel (meta-)cognitive self-help approach for obsessive-compulsive disorder (“myMCT”). J Obsessive Compuls Relat Disord, 10:26–34.
  • Hertenstein E, Rose N, Voderholzer U, Heidenreich T, Nissen C, Thiel N et al. (2012) Mindfulness-based cognitive therapy in obsessive-compulsive disorder – A qualitative study on patients’ experiences. BMC Psychiatry, 12.
  • Hayes SC ve Hoffman SG (2017) The third wave of cognitive behavioral therapy and the rise of process-based care. World Psychiatry, 16:245-246.
  • Hu XZ, Ma JD, Huang P, Shan XW, Zhang ZH, Zhang JH et al. (2015) Highly efficacious cognitive-coping therapy for overt or covert compulsions. Psychiatry Res, 229:732–738.
  • Hu XZ, Wen YS, Ma JD, Han DM, Li YX ve Wang SF (2012) A promising randomized trial of a new therapy for obsessive–compulsive disorder. Brain Behav, 2:443–454.
  • Jelinek L, Hauschildt M, Hottenrott B, Kellner M ve Moritz S (2018) “Association splitting” versus cognitive remediation in obsessive-compulsive disorder: a randomized controlled trial. J Anxiety Disord, 56:17–25.
  • Jelinek L, Hottenrott B, Miegel FS ve Cludius B (2018) Patients’ perspectives on treatment with metacognitive training for OCD: feasibility and acceptability. Zeitschrift für Neuropsychologie, 29:20–28.
  • Jones MK, Harris L ve Vaccaro LD (2012) The efficacy of self-administered danger ideation reduction therapy for a 50-year old woman with a 20 year history of obsessive-compulsive disorder: A case studyInt J Innov Res Sci Eng Technol, 6:1798-1803.
  • Key BL, Rowa K, Bieling P, McCabe R ve Pawluk EJ (2017) Mindfulness‐based cognitive therapy as an augmentation treatment for obsessive–compulsive disorder. Clin Psychol Psychother, 24:1109–1120.
  • Kumar A, Sharma MP, Narayanaswamy C, Kandavel T ve Janardhan Reddy YC (2016) Efficacy of mindfulness‑integrated cognitive behavior therapy in patients with predominant obsessions. Indian J Psychiatry, 58:367-371.
  • Külz AK, Landmann S, Cludius B, Rose N, Heidenreich T, Jelinek L et al. (2019) Mindfulness-based cognitive therapy (MBCT) in patients with obsessive–compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci, 269:223–233.
  • Landmann S, Cludius B, Tuschen-Caffier B, Moritz S ve Külz AK (2020) Changes in the daily life experience of patients with obsessive-compulsive disorder following mindfulness-based cognitive therapy: looking beyond symptom reduction using ecological momentary assessment. Psychiatry Res, 286.
  • Leeuwerik T, Cavanagh K ve Strauss C (2019) Patient adherence to cognitive behavioural therapy for obsessive-compulsive disorder: a systematic review and meta-analysis. J Anxiety Disord, 68:102-135.
  • Ma JD, Wang CH, Li HF, Zhang XL, Zhang YL, Hou YH et al. (2013) Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial. J Psychiatr Res, 47:1785-1790.
  • Manjula M ve Sudhir PM (2019) New‑wave behavioral therapies in obsessive‑compulsive disorder: moving toward integrated behavioral therapies Indian J Psychiatry, 61:104-113.
  • Maqbool M, Sengar KS, Kumar M ve Uparikar PD (2017) Efficacy of danger ideation reduction therapy in obsessive‑compulsive disorder washer with poor insight: a case study and literature review. Indian J Psychol Med, 39:523-526.
  • Melchior K, Franken IHA ve van der Heiden C (2018) Metacognitive therapy for obsessive-compulsive disorder: a case report. Bull Menninger Clin 82:375-389.
  • Miegel F, Cludius B, Hottenrott B, Demiralay C, Sure A ve Jelinek L (2020) Session-specific effects of the metacognitive training for obsessive-compulsive disorder (MCTOCD). Psychother Res, 30:474–486.
  • Mokdad AH, Forouzanfar MH, Daoud F, Mokdad A, El Bcheraoui C, Moradi-Lakeh, M et al. (2016) Global burden of diseases, injuries, and risk factors for young people’s health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 387:2383–2401.
  • Moritz S, Hauschildt M, Murray SC, Pedersen A, Krausz M ve Jelinek L (2018) New wine in an old bottle? Evaluation of myMCT as an integrative bibliotherapy for obsessive-compulsive disorder. J Obsessive Compuls Relat Disord, 16:88–97.
  • Moritz S, Jelinek L, Hauschildt M ve Naber D (2010) How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder. Dialogues Clin Neurosci, 12:209-219.
  • Ong CW, Clyde JW, Bluett EJ, Levin ME ve Twohig MP (2016) Dropout rates in exposure with response prevention forobsessive-compulsive disorder: what do the data really say? J Anxiety Disord, 40:8–17.
  • Orsillo SM ve Roemer L (2005) Acceptance And Mindfulness-Based Approaches To Anxiety Conceptualization And Treatment, New York, Springer.
  • Öst LG, Havnen A, Hansen B ve Kvale G (2015) Cognitive behavioral treatments of obsessive–compulsive disorder: a systematic review and meta-analysis of studies published 1993–2014. Clin Psychol Rev, 40:156–169.
  • Papageorgiou C, Carlile K, Thorgaard S, Waring H, Haslam J, Horne L et al. (2018) Group cognitive-behavior therapy or group metacognitive therapy for obsessive-compulsive disorder? Benchmarking and comparative effectiveness in a routine clinical service. Front Psychol, 9:1-10.
  • Rohani F, Rasouli-Azad M, Twohig MP, Ghoreishi FS, Lee EB ve Akbari H (2018) Preliminary test of group acceptance and commitment therapy on obsessive-compulsive disorder for patients on optimal dose of selective serotonin reuptake inhibitors. J Obsessive Compuls Relat Disord, 16:8–13.
  • Rupp C, Jürgens C, Doebler P, Andor F ve Buhlmann U (2019). A randomized waitlist-controlled trial comparing detached mindfulness and cognitive restructuring in obsessive-compulsive disorder. PLoS One, 14:1-19.
  • Ruscio AM, Stein DJ, Chiu WT ve Kessler RC (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry, 15:53–63.
  • Selchen S, Hawley LL, Regev R, Richter P ve Rector NA (2018) Mindfulness-based cognitive therapy for OCD: stand-alone and post-CBT augmentation approaches. Int J Cogn Ther, 11:58–79.
  • Sguazzin CMG, Key BL, Rowa K, Bieling PJ ve McCabe RE (2017) Mindfulness-based cognitive therapy for residual symptoms in obsessive-compulsive disorder: a qualitative analysis. Mindfulness, 8:190–203.
  • Steketee G ve Barlow DH (2002) Obsessive–Compulsive Disorder. Anxiety And Its Disorders: The Nature And Treatment of Anxiety and Panic, New York, The Guilford Press.
  • Strauss C, Lea L, Hayward M, Forrester E, Leeuwerik T, Jones AM et al. (2018) Mindfulness-based exposure and response prevention for obsessive compulsive disorder: findings from a pilot randomised controlled trial. J Anxiety Disord, 57:39–47.
  • The National Institute for Health and Clinical Excellence (2006) Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. The British Psychological Society and The Royal College of Psychiatrists.
  • Thompson BL, Twohig MP ve Luoma JB (2020) Psychological flexibility as shared process of change in acceptance and commitment therapy and exposure and response prevention for obsessive–compulsive disorder: a single case design study. Behavior Therapy.
  • Twohig MP, Abramowitz JS, Smith BM, Fabricant LE, Jacoby RJ, Morrison KI et al. (2018) Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: a randomized controlled trial. Behav Res Ther, 108:1–9.
  • Twohig MP, Hayes SC, Plumb JC, Pruitt, LD, Collins AB, Hazlett-Stevens H et al. (2010a) A randomized clinical trial of acceptance and commitment therapy vs. progressive relaxation training for obsessive compulsive disorder. J Consult Psychol, 78:705-716.
  • Twohig MP, Plumb Vilardaga JC, Levin ME ve Hayes SC (2015) Changes in psychological flexibility during acceptance and commitment therapy for obsessive compulsive disorder. J Contextual Behav Sci, 4:196–202. Twohig MP, Whittal ML, Cox JM ve Gunter R (2010b) An initial investigation into the processes of change in ACT, CT, and ERP for OCD. Int J Behav Consult Ther, 6:67-83.
  • Vaccaro LD, Jones MK, Menzies RG ve Wootton BM (2010) Danger ideation reduction therapy for obsessive–compulsive checking: preliminary findings. Cognitive Behaviour Therapy, 39:293–301.
  • Vaccaro LD, Jones MK, Menzies RG ve Wootton BM (2014) The treatment of obsessive-compulsive checking: a randomised trial comparing danger ideation reduction therapy with exposure and response prevention. J. Clin. Psychol., 18:74–95.
  • Vakil Y ve Gharraee B (2014) The effectiveness of acceptance and commitment therapy in treating a case of obsessive compulsive disorder. Iran J Psychiatry, 9:115-117.
  • Vakili Y ve Gharraee B ve Habibi (2015) Acceptance and commitment therapy, selective serotonin reuptake inhibitors, and their combination in the improvement of obsessive–compulsive symptoms and experiential avoidance in patients with obsessive–compulsive disorder. Iran J Psychiatry Behav Sci, 9:845.
  • Van der Heiden C, van Rossen K, Dekker A, Damstra M ve Deen M (2016). Metacognitive therapy for obsessive–compulsive disorder: a pilot study. J Obsessive Compuls Relat Disord, 9:24–29.
  • Wahl K, Huelle J, Zurowski B ve Kordon A (2012) Managing obsessive thoughts during brief exposure: an experimental study comparing mindfulness-based strategies and distraction in obsessive–compulsive disorder. Int J Cogn Ther.
  • Wheeler CHB (2017) Acceptance and commitment therapy-specific processes in the psychotherapeutic treatment of obsessive compulsive disorder: a single case study. Clinical Case Studies, 16:313–327.
  • World Health Organization (2017) Depression and other common mental disorders: global health estimates.
  • Wilkinson-Tough M, Bocci L, Thorne K ve Herlihy J (2010) Is mindfulness-based therapy an effective intervention for obsessive–intrusive thoughts: a case series. Clin Psychol Psychother, 17:250–268.
  • Yıldız E (2018) Psikoz sağaltımında kabul ve kararlılık terapisinin etkileri: sistematik bir derleme. I. Uluslararası Battalgazi Multi Disipliner Çalışmalar Kongresi, 7-9 Aralık 2018, Malatya – Türkiye. Tam Metin Kitabı Cilt II.
Birincil Dil tr
Konular Psikoloji, Klinik
Bölüm Derleme
Yazarlar

Orcid: 0000-0003-0438-2416
Yazar: Gizem ONARAL (Sorumlu Yazar)
Kurum: ERCİYES ÜNİVERSİTESİ, EDEBİYAT FAKÜLTESİ
Ülke: Turkey


Tarihler

Kabul Tarihi : 13 Ekim 2020
Yayımlanma Tarihi : 30 Haziran 2021

Bibtex @derleme { pgy779029, journal = {Psikiyatride Güncel Yaklaşımlar}, issn = {1309-0658}, eissn = {1309-0674}, address = {}, publisher = {Lut TAMAM}, year = {2021}, volume = {13}, pages = {292 - 331}, doi = {10.18863/pgy.779029}, title = {Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme}, key = {cite}, author = {Onaral, Gizem} }
APA Onaral, G . (2021). Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme . Psikiyatride Güncel Yaklaşımlar , 13 (2) , 292-331 . DOI: 10.18863/pgy.779029
MLA Onaral, G . "Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme" . Psikiyatride Güncel Yaklaşımlar 13 (2021 ): 292-331 <https://dergipark.org.tr/tr/pub/pgy/issue/58189/779029>
Chicago Onaral, G . "Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme". Psikiyatride Güncel Yaklaşımlar 13 (2021 ): 292-331
RIS TY - JOUR T1 - Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme AU - Gizem Onaral Y1 - 2021 PY - 2021 N1 - doi: 10.18863/pgy.779029 DO - 10.18863/pgy.779029 T2 - Psikiyatride Güncel Yaklaşımlar JF - Journal JO - JOR SP - 292 EP - 331 VL - 13 IS - 2 SN - 1309-0658-1309-0674 M3 - doi: 10.18863/pgy.779029 UR - https://doi.org/10.18863/pgy.779029 Y2 - 2020 ER -
EndNote %0 Psikiyatride Güncel Yaklaşımlar Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme %A Gizem Onaral %T Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme %D 2021 %J Psikiyatride Güncel Yaklaşımlar %P 1309-0658-1309-0674 %V 13 %N 2 %R doi: 10.18863/pgy.779029 %U 10.18863/pgy.779029
ISNAD Onaral, Gizem . "Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme". Psikiyatride Güncel Yaklaşımlar 13 / 2 (Haziran 2021): 292-331 . https://doi.org/10.18863/pgy.779029
AMA Onaral G . Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme. pgy. 2021; 13(2): 292-331.
Vancouver Onaral G . Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme. Psikiyatride Güncel Yaklaşımlar. 2021; 13(2): 292-331.
IEEE G. Onaral , "Obsesif-Kompulsif Bozuklukta Üçüncü Kuşak Terapilerin Etkililiği: Bir Gözden Geçirme", Psikiyatride Güncel Yaklaşımlar, c. 13, sayı. 2, ss. 292-331, Haz. 2021, doi:10.18863/pgy.779029